Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations-Reference-Cited by-同舟云学术

Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations

Published:1984-10 Issue:1 Volume:106 Page:133-139
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

De Vries David J.,Beart Philip M.

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site;Beart;Neurosci. Lett.,1982

2. Neurochemical studies of the mesolimbic dopaminergic pathway: [3H]spiperone labels two binding sites in homogenates of the nucleus accumbens of rat brain;Beart;J. Neurochem.,1982

3. Dopamine inhibits 32Pi incorporation into phosphatidylinositol in the anterior pituitary gland of the rat;Canonico;Endocrinology,1982

4. Differential inhibition of vascular smooth muscle responses to α1 and α2-adrenoceptor agonists by diltiazem and verapamil;Cavero;Circ. Res.,1983

5. Advanced Inorganic Chemistry;Cotton,1980

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition;Psychopharmacology;2004-09-25

2. Pharmacological Options for the Treatment of Tourette??s Disorder;Drugs;2001

3. Effects of Isradipine, a Dihydropyridine-Class Calcium Channel Antagonist, on D-Methamphetamine-Induced Cognitive and Physiological Changes in Humans;Neuropsychopharmacology;2000-05

4. Genetics, drugs and environmental factors in Parkinson's disease: a case-control study;Arquivos de Neuro-Psiquiatria;1999-06

5. Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice;European Journal of Pharmacology;1999-01